Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 330

The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.

Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study

Open access
Walli-Attaei, Marjan, Joseph, Philip, Rosengren, Annika, Chow, Clara K, Rangarajan, Sumathy, Lear, Scott A, AlHabib, Khalid F, Davletov, Kairat, Dans, Antonio, Lanas, Fernando, Yeates, Karen, Poirier, Paul, Teo, Koon K, Bahonar, Ahmad, Camilo, Felix, Chifamba, Jephat, Diaz, Rafael, Didkowska, Joanna A, Irazola, Vilma, Ismail, Rosnah, Kaur, Manmeet, Khatib, Rasha, Liu, Xiaoyun, Mańczuk, Marta, Miranda, J Jaime, Oguz, Aytekin, Perez-Mayorga, Maritza, Szuba, Andrzej, Tsolekile, Lungiswa P, Prasad Varma, Ravi, Yusufali, Afzalhussein, Yusuf, Rita, Wei, Li, Anand, Sonia S, Yusuf, Salim·2020·The Lancet

Abstract

BACKGROUND Some studies, mainly from high-income countries (HICs), report that women receive less care (investigations and treatments) for cardiovascular disease than do men and might have a higher risk of death. However, very few studies systematically report risk factors, use of primary or secondary prevention medications, incidence of cardiovascular disease, or death in populations drawn from the community. Given that most cardiovascular disease occurs in low-income and middle-income countries (LMICs), there is a need for comprehensive information comparing treatments and outcomes between women and men in HICs, middle-income countries, and low-income countries from community-based population studies. METHODS In the Prospective Urban Rural Epidemiological study (PURE), individuals aged 35-70 years from urban and rural communities in 27 countries were considered for inclusion. We recorded information on participants' sociodemographic characteristics, risk factors, medication use, cardiac investigations, and interventions. 168 490 participants who enrolled in the first two of the three phases of PURE were followed up prospectively for incident cardiovascular disease and death. FINDINGS From Jan 6, 2005 to May 6, 2019, 202 072 individuals were recruited to the study. The mean age of women included in the study was 50·8 (SD 9·9) years compared with 51·7 (10) years for men. Participants were followed up for a median of 9·5 (IQR 8·5-10·9) years. Women had a lower cardiovascular disease risk factor burden using two different risk scores (INTERHEART and Framingham). Primary prevention strategies, such as adoption of several healthy lifestyle behaviours and use of proven medicines, were more frequent in women than men. Incidence of cardiovascular disease (4·1 [95% CI 4·0-4·2] for women vs 6·4 [6·2-6·6] for men per 1000 person-years; adjusted hazard ratio [aHR] 0·75 [95% CI 0·72-0·79]) and all-cause death (4·5 [95% CI 4·4-4·7] for women vs 7·4 [7·2-7·7] for men per 1000 person-years; aHR 0·62 [95% CI 0·60-0·65]) were also lower in women. By contrast, secondary prevention treatments, cardiac investigations, and coronary revascularisation were less frequent in women than men with coronary artery disease in all groups of countries. Despite this, women had lower risk of recurrent cardiovascular disease events (20·0 [95% CI 18·2-21·7] versus 27·7 [95% CI 25·6-29·8] per 1000 person-years in men, adjusted hazard ratio 0·73 [95% CI 0·64-0·83]) and women had lower 30-day mortality after a new cardiovascular disease event compared with men (22% in women versus 28% in men; p<0·0001). Differences between women and men in treatments and outcomes were more marked in LMICs with little differences in HICs in those with or without previous cardiovascular disease. INTERPRETATION Treatments for cardiovascular disease are more common in women than men in primary prevention, but the reverse is seen in secondary prevention. However, consistently better outcomes are observed in women than in men, both in those with and without previous cardiovascular disease. Improving cardiovascular disease prevention and treatment, especially in LMICs, should be vigorously pursued in both women and men. FUNDING Full funding sources are listed at the end of the paper (see Acknowledgments).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0140-6736(20)30543-2

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 48 references

Cited by

See all 330

Metadata

Authors
Walli-Attaei, M., Joseph, P., Rosengren, A., Chow, C. K., Rangarajan, S., Lear, S. A., AlHabib, K. F., Davletov, K., Dans, A., Lanas, F., Yeates, K., Poirier, P., Teo, K. K., Bahonar, A., Camilo, F., Chifamba, J., Diaz, R., Didkowska, J. A., Irazola, V., Ismail, R., Kaur, M., Khatib, R., Liu, X., Mańczuk, M., Miranda, J. J., Oguz, A., Perez-Mayorga, M., Szuba, A., Tsolekile, L. P., Prasad Varma, R., Yusufali, A., Yusuf, R., Wei, L., Anand, S. S., & Yusuf, S.
Venue
The Lancet
Publisher
Elsevier BV
Published
2020-07
Volume
396
Issue
10244
Pages
97-109
ISSN
  • 0099-5355 (ISSN-L)
  • 0140-6736
OpenAlex
W3026637300
Cited by
330
References
48
FWCI
34.08
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. https://app.cochat.ai/papers/10.1016/s0140-6736(20)30543-2
The paper
Walli-Attaei, M., Joseph, P., Rosengren, A., Chow, C. K., Rangarajan, S., Lear, S. A., AlHabib, K. F., Davletov, K., Dans, A., Lanas, F., Yeates, K., Poirier, P., Teo, K. K., Bahonar, A., Camilo, F., Chifamba, J., Diaz, R., Didkowska, J. A., Irazola, V., . . . Yusuf, S. (2020). Variations between women and men in risk factors, treatments, cardiovascular disease incidence, and death in 27 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. The Lancet. https://doi.org/10.1016/s0140-6736(20)30543-2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.